Expression of dentatorubral-pallidoluysian atrophy (DRPLA) proteins in patients

Neurosci Lett. 1997 Mar 28;225(1):53-6. doi: 10.1016/s0304-3940(97)00189-4.

Abstract

The genetic defect dentatorubral-pallidoluysian atrophy (DRPLA) is caused by expansion of a CAG trinucleotide repeat. The mutant gene is translated into protein whose electrophoretic mobility correlates to the number of expanded CAG trinucleotide repeats, indicating that the protein carries an expanded glutamine repeat. Using two polyclonal antibodies raised against the DRPLA gene product in immunoblotting, we determined the untruncated DRPLA proteins, and showed that the amounts of mutant and wild-type DRPLA proteins were similar in DRPLA brain tissues and lymphoblastoid cells, suggesting that regulation of the level of translation of the DRPLA gene is not central to the development of the disease.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Cells, Cultured
  • Female
  • Glutamine / genetics
  • Humans
  • Huntingtin Protein
  • Immunoblotting
  • Lymphocytes / chemistry*
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / genetics
  • Nuclear Proteins / genetics
  • Oligonucleotides / genetics
  • Point Mutation*
  • Repetitive Sequences, Nucleic Acid
  • Stem Cells / chemistry*

Substances

  • HTT protein, human
  • Huntingtin Protein
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Oligonucleotides
  • atrophin-1
  • Glutamine